SU
SurgePays, Inc.
SURG · NASDAQ
$0.17 -16.58% (-$0.03)
1M -37.64%
Market Cap $4.35M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.2
15.5% upside
Current Price
$0.17
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SURG is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.06x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 22.32%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 47.89%
Op. margin 53.69%
FCF margin 19.03%
Quality
79 /100
Excellent ROA 347.62%
Asset turnover 7.26x
ROIC 1,256.82%
Debt
0 /100
High Int. coverage -10.62x
Current ratio 0.19x
Net debt/EBITDA N/A
Stability
11 /100
Unstable Rev. volatility 35.29%
EPS volatility 1,587.74%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SURG
Online
Sector
Technology
Industry
Software - Application
CEO
Kevin Brian Cox
Employees
125
Headquarters
Bartlett
Upcoming events
11 NOV
Earnings
Upcoming earnings report